Cambrex Corp Receivables Turnover Ratio (CBM), from the third quarter 2019 to the third quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cambrex Corp  (CBM)
 

Cambrex Accounts Receivables Turnover Ratio from the third quarter 2019 to the third quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Cambrex Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2019 to a ratio of 5.38, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2019. Average receivable collection period, for the Cambrex in Sep 30 2019 quarter, has decreased to 68 days, compared to 71 days, in the Jun 30 2019 quarter.

If we take a look into Healthcare sector 292 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2019 from 2417 to 2418.

What is Receivable Turnover Ratio?
What is Cambrex Corp Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CBM Receivables Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Receivable Change 17.6 % 1.46 % 16.91 % 57.78 % -3.65 %
Y / Y Revenue Change 42.01 % 16.31 % 13.01 % -26.3 % -7.1 %
Receivable Turnover Ratio (TTM) 5.38 5.17 4.96 4.94 6.19
CBM's Total Ranking # 2418 # 2417 # 2365 # 2797 # 2417
Accounts Receivable average collection period days 68 71 74 74 59
Seq. Receivable Change -13.4 % 30.29 % -40.57 % 75.37 % -25.28 %
Seq. Revenue Change -15.99 % 10.91 % 18.7 % 28.4 % -31.19 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 83
Healthcare Sector # 293
Overall Market # 2418

Receivable Turnover Ratio Statistics
High Average Low
0.88 0.75 0.42
(Jun 30 2016)   (Jun 30 2019)





CBM Company Profile • Back to CBM Efficiency Comparisons • Compare CBM Receivables Turnover Ratio to its Competitors

Financial Statements
Cambrex's Accounts Receivable $ 102 Millions Visit CBM's Balance sheet
Cambrex's Sales TTM $ 619 Millions Visit CBM's Income Statement
Sources of CBM's Revenues Visit CBM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CBM's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CBM's Growth Rates CBM's Roa CBM's Inventory Turnover Ratio CBM's Dividend Comparisons
CBM's Profitability Ratios CBM's Roi CBM's Asset Turnover Ratio CBM's Dividend Growth
CBM's Valuation Ratios CBM's Roe CBM's Financial Strength Ratios CBM's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2019 Receivable at quarter ending Sep 30 2019
Aveo Pharmaceuticals Inc   16.41 $ 29.947  Millions$ 1.825  Millions
Acadia Healthcare Company Inc   16.31 $ 5,490.769  Millions$ 336.663  Millions
Vtv Therapeutics Inc   15.89 $ 7.279  Millions$ 0.458  Millions
Therapeutic Solutions International Inc   15.46 $ 0.021  Millions$ 0.001  Millions
Chemed Corporation  15.31 $ 1,873.739  Millions$ 122.418  Millions
Cv Sciences Inc   15.28 $ 58.592  Millions$ 3.835  Millions
Seres Therapeutics Inc   15.02 $ 37.512  Millions$ 2.497  Millions
Mannkind Corporation  14.98 $ 63.076  Millions$ 4.211  Millions
Kyntra Bio Inc   14.96 $ 356.657  Millions$ 23.846  Millions
Ainos Inc   14.72 $ 0.015  Millions$ 0.001  Millions
Geovax Labs Inc   14.67 $ 1.649  Millions$ 0.112  Millions
Plx Pharma Inc   14.55 $ 0.829  Millions$ 0.057  Millions
Corcept Therapeutics Inc  14.45 $ 285.422  Millions$ 19.746  Millions
Jrsis Health Care Corp  14.41 $ 30.719  Millions$ 2.132  Millions
Neurometrix Inc   13.67 $ 11.294  Millions$ 0.826  Millions
Regeneron Pharmaceuticals Inc   13.65 $ 7,729.046  Millions$ 566.075  Millions
Musclepharm Corporation  13.63 $ 82.413  Millions$ 6.048  Millions
Verastem Inc   13.51 $ 15.049  Millions$ 1.114  Millions
Bespoke Extracts Inc  13.03 $ 0.062  Millions$ 0.005  Millions
Emmaus Life Sciences Inc   12.96 $ 7.458  Millions$ 0.575  Millions
Otonomy Inc   12.83 $ 0.715  Millions$ 0.056  Millions
Reflect Scientific Inc  12.57 $ 1.410  Millions$ 0.112  Millions
Parallax Health Sciences Inc   12.51 $ 0.079  Millions$ 0.006  Millions
Tvardi Therapeutics Inc   12.36 $ 20.908  Millions$ 1.691  Millions
La Jolla Pharmaceutical Company  11.95 $ 19.988  Millions$ 1.673  Millions
Zynex inc   11.84 $ 40.647  Millions$ 3.433  Millions
Integrated Biopharma Inc  11.83 $ 51.079  Millions$ 4.317  Millions
Arvinas Inc   11.78 $ 41.523  Millions$ 3.526  Millions
Exact Sciences Corporation  11.75 $ 723.699  Millions$ 61.609  Millions
Rigel Pharmaceuticals Inc  11.73 $ 82.632  Millions$ 7.044  Millions

Date modified: 2026-08-29T14:49:27+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.